Literature DB >> 11259108

Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease.

J Quinn1, F Davis, W R Woodward, F Eckenstein.   

Abstract

A causative role for nitric oxide has been postulated in a number of neurodegenerative diseases. Using histochemical and immunohistochemical methods, we examined the effect of beta-amyloid plaques on nitric oxide-producing cells in transgenic mice which overexpress a mutant human amyloid precursor protein (APP). In 14-month-old animals, nitric oxide synthase (NOS)-positive dystrophic neurites were observed frequently in the cerebral cortex and hippocampus of all of 16 plaque-bearing transgenic animals and in none of 16 wild-type animals. Double labeling of NOS and beta-amyloid revealed that 90% of beta-amyloid plaques were associated with NOS-containing dystrophic neurites. In 7-month-old animals, beta-amyloid plaques were very rare, but those present were frequently associated with NOS-positive neuritic dystrophy. We conclude that beta-amyloid plaques induce neuritic dystrophy in cortical neurons containing NOS in this model of AD, and hypothesize that this finding may be relevant to the mechanism of beta-amyloid neurotoxicity in human AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259108     DOI: 10.1006/exnr.2000.7598

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

1.  Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.

Authors:  Xue-Mei Zhang; Yan Cai; Kun Xiong; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

2.  Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex.

Authors:  Xue-Mei Zhang; Kun Xiong; Yan Cai; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Peter R Patrylo; Robert G Struble; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2010-02       Impact factor: 3.386

Review 3.  Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.

Authors:  Katarzyna Urszula Domek-Łopacińska; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

4.  Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease.

Authors:  Bruce L Martin; Abigail M Tokheim; Patrick T McCarthy; Brendan S Doms; Andrew A Davis; Ian M Armitage
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

5.  Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.

Authors:  Richard McClure; Henry Ong; Vaibhab Janve; Shawn Barton; Meiying Zhu; Bo Li; Mary Dawes; W Gray Jerome; Adam Anderson; Pierre Massion; John C Gore; Wellington Pham
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.